Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis

Altamura, 2011, An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses, European Archives of Psychiatry and Clinical Neuroscience, 261, 489, 10.1007/s00406-011-0196-4 Angst, 2002, Mortality of patients with mood disorders: follow-up over 34–38 years, Journal of Affective Disorders, 68, 167, 10.1016/S0165-0327(01)00377-9 Banks, 1995, Passage of cytokines across the blood–brain barrier, Neuroimmunomodulation, 2, 241, 10.1159/000097202 Barbosa, 2011, Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder, European Archives of Psychiatry and Clinical Neuroscience, 261, 139, 10.1007/s00406-010-0116-z Barbosa, 2012, Increased levels of adipokines in bipolar disorder, Journal of Psychiatric Research, 46, 389, 10.1016/j.jpsychires.2011.11.010 Barbosa, 2012, Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers, Journal of Affective Disorders, 137, 151, 10.1016/j.jad.2011.12.034 Behrens, 2008, Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia, Journal of Neuroscience, 28, 13957, 10.1523/JNEUROSCI.4457-08.2008 Bellani, 2010, Altered mRNA levels of chemokines and cytokines in schizophrenia and bipolar disorder, Schizophrenia Research, 117, 251, 10.1016/j.schres.2010.02.390 Berk, 2009, Neuroprogression: pathways to progressive brain changes in bipolar disorder, International Journal of Neuropsychopharmacology, 12, 441, 10.1017/S1461145708009498 Berk, 2011, Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors, Neuroscience and Biobehavioral Reviews, 35, 804, 10.1016/j.neubiorev.2010.10.001 Beumer, 2012, The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes, Journal of Leukocyte Biology, 92, 959, 10.1189/jlb.0212100 Boufidou, 2004, Cytokine production in bipolar affective disorder patients under lithium treatment, Journal of Affective Disorders, 82, 309, 10.1016/j.jad.2004.01.007 Breunis, 2003, High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder, Biological Psychiatry, 53, 157, 10.1016/S0006-3223(02)01452-X Brietzke, 2009, Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder, Brain, Behavior, and Immunity, 23, 1079, 10.1016/j.bbi.2009.04.008 Brietzke, 2011, Cytokines in bipolar disorder: recent findings, deleterious effects but promise for future therapeutics, CNS Spectrums, 16, 10.1017/S1092852912000338 Brietzke, 2009, Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder, Journal of Affective Disorders, 116, 214, 10.1016/j.jad.2008.12.001 Brietzke, 2010, Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor, Bipolar Disorders, 12, 453, 10.1111/j.1399-5618.2010.00822.x Cetin, 2012, Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms, BMC Psychiatry, 12, 158, 10.1186/1471-244X-12-158 Chae, 2001, Blood pressure and inflammation in apparently healthy men, Hypertension, 38, 399, 10.1161/01.HYP.38.3.399 Chen, 2002, TNF-R1 signaling: a beautiful pathway, Science, 296, 1634, 10.1126/science.1071924 Couzin-Frankel, 2010, Inflammation bares a dark side, Science, 330, 1621, 10.1126/science.330.6011.1621 Cunha, 2008, Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder, European Archives of Psychiatry and Clinical Neuroscience, 258, 300, 10.1007/s00406-007-0797-0 Dahlman, 2005, A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects, Journal of Clinical Endocrinology and Metabolism, 90, 5834, 10.1210/jc.2005-0369 Dantzer, 2008, From inflammation to sickness and depression: when the immune system subjugates the brain, Nature Reviews Neuroscience, 9, 46, 10.1038/nrn2297 De Berardis, 2008, Evaluation of C-reactive protein and total serum cholesterol in adult patients with bipolar disorder, International Journal of Immunopathology and Pharmacology, 21, 319, 10.1177/039463200802100208 DerSimonian, 1986, Meta-analysis in clinical trials, Controlled Clinical Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Dickerson, 2010, Immunologic abnormalities associated with mania, Brain, Behavior, and Immunity, 24, S54, 10.1016/j.bbi.2010.07.178 Dickerson, 2009, C-Reactive protein in acute mania: a longitudinal study, Bipolar Disorders, 11, 34 Dickerson, 2007, Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31, 952, 10.1016/j.pnpbp.2007.02.018 do Prado, 2012, Reduced regulatory T cells are associated with higher levels of Th1/TH17 cytokines and activated MAPK in type 1 bipolar disorder, Psychoneuroendocrinology Dowlati, 2010, A meta-analysis of cytokines in major depression, Biological Psychiatry, 67, 446, 10.1016/j.biopsych.2009.09.033 Drexhage, 2011, Immune activation in psychiatric and pre-psychiatric disease, European Psychiatry, 26, 10.1016/S0924-9338(11)73793-2 Drexhage, 2011, The activation of monocyte and T cell networks in patients with bipolar disorder, Brain, Behavior, and Immunity, 25, 1206, 10.1016/j.bbi.2011.03.013 Drexhage, 2010, The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder, Expert Review of Neurotherapeutics, 10, 59, 10.1586/ern.09.144 Drexhage, 2010, Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients, International Journal of Neuropsychopharmacology, 13, 1369, 10.1017/S1461145710000799 Duman, 2004, Role of neurotrophic factors in the etiology and treatment of mood disorders, Neuromolecular Medicine, 5, 11, 10.1385/NMM:5:1:011 Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 Egger, 1998, Spurious precision? Meta-analysis of observational studies, BMJ, 316, 140, 10.1136/bmj.316.7125.140 Egger, 1997, Meta-analysis. Potentials and promise, BMJ, 315, 1371, 10.1136/bmj.315.7119.1371 Egger, 1997, Meta-analysis: principles and procedures, BMJ, 315, 1533, 10.1136/bmj.315.7121.1533 Ekdahl, 2003, Inflammation is detrimental for neurogenesis in adult brain, Proceedings of the National Academy of Sciences of the United States of America, 100, 13632, 10.1073/pnas.2234031100 Esposito, 2003, Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial, JAMA, 289, 1799, 10.1001/jama.289.14.1799 Fernandes, 2011, Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis, Journal of Psychiatric Research, 45, 995, 10.1016/j.jpsychires.2011.03.002 Fontenot, 2005, A function for interleukin 2 in Foxp3-expressing regulatory T cells, Nature Immunology, 6, 1142, 10.1038/ni1263 Gardner, 2011, Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 730, 10.1016/j.pnpbp.2010.07.030 Gildengers, 2012, Correlates of treatment response in depressed older adults with bipolar disorder, Journal of Geriatric Psychiatry and Neurology, 25, 37, 10.1177/0891988712436685 Goldstein, 2009, Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature, Journal of Clinical Psychiatry, 70, 1078, 10.4088/JCP.08r04505 Grande, 2012, Mediators of allostasis and systemic toxicity in bipolar disorder, Physiology and Behavior, 106, 46, 10.1016/j.physbeh.2011.10.029 Guloksuz, 2012, Evidence for an association between tumor necrosis factor-alpha levels and lithium response, Journal of Affective Disorders, 143, 148, 10.1016/j.jad.2012.04.044 Guloksuz, 2010, Cytokine levels in euthymic bipolar patients, Journal of Affective Disorders, 126, 458, 10.1016/j.jad.2010.04.027 Haddad, 2002, Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamic-pituitary-adrenal revolving axis, Journal of Neuroimmunology, 133, 1, 10.1016/S0165-5728(02)00357-0 Higgins, 2002, Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice, Journal of Health Services Research and Policy, 7, 51, 10.1258/1355819021927674 Himmerich, 2005, Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium, Psychopharmacology, 179, 447, 10.1007/s00213-004-2038-9 Hope, 2011, Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia, Journal of Psychiatric Research, 45, 1608, 10.1016/j.jpsychires.2011.08.003 Hope, 2009, Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor, Bipolar Disorders, 11, 726, 10.1111/j.1399-5618.2009.00757.x Hope, 2011, Interleukin 1 receptor antagonist and tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder, Schizophrenia Bulletin, 37, 115 Hornig, 1998, Positive and negative acute phase proteins in affective subtypes, Journal of Affective Disorders, 49, 9, 10.1016/S0165-0327(97)00180-8 Hsiao, 2009, Neuropsychological functions in patients with bipolar I and bipolar II disorder, Bipolar Disorders, 11, 547, 10.1111/j.1399-5618.2009.00723.x Huang, 2007, High-sensitivity C-reactive protein levels in patients with major depressive disorder and bipolar mania, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31, 370, 10.1016/j.pnpbp.2006.09.010 Haack, 1999, Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis, Journal of Psychiatric Research, 33, 407, 10.1016/S0022-3956(99)00021-7 Imhof, 2001, Effect of alcohol consumption on systemic markers of inflammation, Lancet, 357, 763, 10.1016/S0140-6736(00)04170-2 Imura, 1997, Endocrine and metabolic manifestations associated with infectious and inflammatory diseases, FEMS Immunology and Medical Microbiology, 18, 221, 10.1111/j.1574-695X.1997.tb01049.x Jamrozinski, 2009, Neurocognitive functions in euthymic bipolar patients, Acta Psychiatrica Scandinavica, 119, 365, 10.1111/j.1600-0447.2008.01320.x Jones, 2001, The soluble interleukin 6 receptor: mechanisms of production and implications in disease, FASEB Journal, 15, 43, 10.1096/fj.99-1003rev Jones, 2002, The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex, Biochimica et Biophysica Acta, 1592, 251, 10.1016/S0167-4889(02)00319-1 Kang, 2012, Lithium pretreatment reduces brain injury after intracerebral hemorrhage in rats, Neurological Research, 34, 447, 10.1179/1743132812Y.0000000015 Kapczinski, 2011, Peripheral biomarkers and illness activity in bipolar disorder, Journal of Psychiatric Research, 45, 156, 10.1016/j.jpsychires.2010.05.015 Kapczinski, 2010, A systemic toxicity index developed to assess peripheral changes in mood episodes, Molecular Psychiatry, 15, 784, 10.1038/mp.2009.112 Kapczinski, 2009, The potential use of biomarkers as an adjunctive tool for staging bipolar disorder, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 33, 1366, 10.1016/j.pnpbp.2009.07.027 Kapczinski, 2008, Allostatic load in bipolar disorder: implications for pathophysiology and treatment, Neuroscience and Biobehavioral Reviews, 32, 675, 10.1016/j.neubiorev.2007.10.005 Kauer-Sant'Anna, 2011, Brain-derived neurotrophic factor and inflammatory markers in patients with early-vs. late-state bipolar disorder, Biological Psychiatry, 1, 123S Kauer-Sant'Anna, 2009, Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder, International Journal of Neuropsychopharmacology, 12, 447, 10.1017/S1461145708009310 Kemp, 2010, Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome, Bipolar Disorders, 12, 404, 10.1111/j.1399-5618.2010.00823.x Kim, 2007, Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder, Journal of Affective Disorders, 104, 91, 10.1016/j.jad.2007.02.018 Kim, 2004, T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients, Psychiatry Research, 129, 267, 10.1016/j.psychres.2004.08.005 Kim, 2002, The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs, Molecular Psychiatry, 7, 1107, 10.1038/sj.mp.4001084 Knijff, 2007, An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment, Bipolar Disorders, 9, 743, 10.1111/j.1399-5618.2007.00444.x Knijff, 2006, A relative resistance of T cells to dexamethasone in bipolar disorder, Bipolar Disorders, 8, 740, 10.1111/j.1399-5618.2006.00359.x Kunz, 2011, Serum levels of IL-6, IL-10 and TNF-alpha in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance, Revista Brasileira de Psiquiatria, 33, 268, 10.1590/S1516-44462011005000009 Kunz, 2010, Serum levels of Il6, Il10 and TNF-alpha in patients with bipolar disorder in euthymia and with schizophrenia: differences in pro and anti-inflammatory balance, Biological Psychiatry, 1, 132S Kupfer, 2005, The increasing medical burden in bipolar disorder, JAMA, 293, 2528, 10.1001/jama.293.20.2528 Leboyer, 2012, Can bipolar disorder be viewed as a multi-system inflammatory disease?, Journal of Affective Disorders, 141, 1, 10.1016/j.jad.2011.12.049 Legros, 1985, Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders, European Archives of Psychiatry and Neurological Sciences, 235, 9, 10.1007/BF00380962 Leonard, 2001, The immune system, depression and the action of antidepressants, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 767, 10.1016/S0278-5846(01)00155-5 Lindqvist, 2009, Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity, Biological Psychiatry, 66, 287, 10.1016/j.biopsych.2009.01.030 Liu, 2004, Immunologic variables in acute mania of bipolar disorder, Journal of Neuroimmunology, 150, 116, 10.1016/j.jneuroim.2004.01.006 Maes, 1995, Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers, Journal of Psychiatric Research, 29, 141, 10.1016/0022-3956(94)00049-W Maes, 1997, Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs, Psychiatry Research, 66, 1, 10.1016/S0165-1781(96)02915-0 Maier, 2005, Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study, Journal of Neurotrauma, 22, 822, 10.1089/neu.2005.22.822 Manji, 2000, Neuroplasticity and cellular resilience in mood disorders, Molecular Psychiatry, 5, 578, 10.1038/sj.mp.4000811 Manning, 2008, Postprandial cytokine concentrations and meal composition in obese and lean women, Obesity (Silver Spring), 16, 2046, 10.1038/oby.2008.334 Marie, 1996, Regulation by anti-inflammatory cytokines (IL-4, IL-10, IL-13, TGFbeta)of interleukin-8 production by LPS- and/or TNFalpha-activated human polymorphonuclear cells, Mediators of Inflammation, 5, 334, 10.1155/S0962935196000488 Marz, 1999, Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression, Glia, 26, 191, 10.1002/(SICI)1098-1136(199905)26:3<191::AID-GLIA1>3.0.CO;2-# Marz, 1997, Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation, European Journal of Neuroscience, 9, 2765, 10.1111/j.1460-9568.1997.tb01705.x McIntyre, 2009, Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap, Current Diabetes Reports, 9, 51, 10.1007/s11892-009-0010-0 Middle, 2000, Tumour necrosis factor alpha and bipolar affective puerperal psychosis, Psychiatric Genetics, 10, 195, 10.1097/00041444-200010040-00008 Miller, 2009, Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression, Biological Psychiatry, 65, 732, 10.1016/j.biopsych.2008.11.029 Miller, 2011, Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects, Biological Psychiatry, 70, 663, 10.1016/j.biopsych.2011.04.013 Modabbernia, 2013, Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies, Biological Psychiatry, 10.1016/j.biopsych.2013.01.007 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, 339, b2535, 10.1136/bmj.b2535 Monje, 2003, Inflammatory blockade restores adult hippocampal neurogenesis, Science, 302, 1760, 10.1126/science.1088417 Munkholm, 2012, State-related alterations of gene expression in bipolar disorder: a systematic review, Bipolar Disorders, 14, 684, 10.1111/bdi.12005 Munkholm, 2013, Cytokines in bipolar disorder: a systematic review and meta-analysis, Journal of Affective Disorders, 144, 16, 10.1016/j.jad.2012.06.010 Nahman, 2012, Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells, Innate Immunity, 18, 447, 10.1177/1753425911421512 Naik, 2011, Mitochondrial reactive oxygen species drive proinflammatory cytokine production, Journal of Experimental Medicine, 208, 417, 10.1084/jem.20110367 Nery, 2008, Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study, Human Psychopharmacology, 23, 87, 10.1002/hup.912 Ng, 2008, Oxidative stress in psychiatric disorders: evidence base and therapeutic implications, International Journal of Neuropsychopharmacology, 11, 851, 10.1017/S1461145707008401 O'Brien, 2006, Cytokine profiles in bipolar affective disorder: focus on acutely ill patients, Journal of Affective Disorders, 90, 263, 10.1016/j.jad.2005.11.015 O'Connor, 2009, To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers, Brain, Behavior, and Immunity, 23, 887, 10.1016/j.bbi.2009.04.005 Ortiz-Dominguez, 2007, Immune variations in bipolar disorder: phasic differences, Bipolar Disorders, 9, 596, 10.1111/j.1399-5618.2007.00493.x Padmos, 2008, A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes, Archives of General Psychiatry, 65, 395, 10.1001/archpsyc.65.4.395 Pandey, 2011, Proinflammatory cytokines and brain-derived neurotrophic factor in patients with pediatric bipolar disorders, Biological Psychiatry, 1, 123S Papanicolaou, 2000, Interleukin-6: the endocrine cytokine, Journal of Clinical Endocrinology and Metabolism, 85, 1331, 10.1210/jcem.85.3.6582 Park, 2010, Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction, Cellular Signalling, 22, 977, 10.1016/j.cellsig.2010.01.010 Peters, 2008, Meta-analysis of repeated measures study designs, Journal of Evaluation in Clinical Practice, 14, 941, 10.1111/j.1365-2753.2008.01010.x Pischon, 2003, Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers, Obesity Research, 11, 1055, 10.1038/oby.2003.145 Pollmacher, 2000, Effects of antipsychotic drugs on cytokine networks, Journal of Psychiatric Research, 34, 369, 10.1016/S0022-3956(00)00032-7 Poppitt, 2008, Postprandial response of adiponectin, interleukin-6, tumor necrosis factor-alpha, and C-reactive protein to a high-fat dietary load, Nutrition, 24, 322, 10.1016/j.nut.2007.12.012 Powrie, 1993, Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo, European Journal of Immunology, 23, 3043, 10.1002/eji.1830231147 Prossin, 2010, IL-6 is associated with metabolic syndrome in bipolar disorder, Brain, Behavior, and Immunity, 24, S47, 10.1016/j.bbi.2010.07.155 Quan, 2007, Brain-immune communication pathways, Brain, Behavior, and Immunity, 21, 727, 10.1016/j.bbi.2007.05.005 Rajkowska, 2000, Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells, Biological Psychiatry, 48, 766, 10.1016/S0006-3223(00)00950-1 Rao, 2010, Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients, Molecular Psychiatry, 15, 384, 10.1038/mp.2009.47 Rapaport, 1994, Immune parameters in euthymic bipolar patients and normal volunteers, Journal of Affective Disorders, 32, 149, 10.1016/0165-0327(94)90012-4 Rapaport, 1999, Immune parameters in rapid cycling bipolar patients before and after lithium treatment, Journal of Psychiatric Research, 33, 335, 10.1016/S0022-3956(99)00007-2 Remlinger-Molenda, 2010, Cytokine profiles in bipolar affective disorder during acute episodes and in remission, European Neuropsychopharmacology, 20, S415, 10.1016/S0924-977X(10)70597-6 Remlinger-Molenda, 2012, Selected cytokine profiles during remission in bipolar patients, Neuropsychobiology, 66, 193, 10.1159/000339949 Remlinger, 2009, The effect of mania on cytokine status in bipolar illness, Journal of Cancer Education, 24, S462 Rybakowski, 2000, Antiviral and immunomodulatory effect of lithium, Pharmacopsychiatry, 33, 159 Schneider-Brachert, 2004, Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles, Immunity, 21, 415, 10.1016/j.immuni.2004.08.017 Schroeter, 2011, Glial pathology is modified by age in mood disorders – a systematic meta-analysis of serum S100B in vivo studies, Journal of Affective Disorders, 134, 32, 10.1016/j.jad.2010.11.008 Sistrom, 2000, A simple method for obtaining original data from published graphs and plots, AJR. American Journal of Roentgenology, 174, 1241, 10.2214/ajr.174.5.1741241 Smith, 1991, The macrophage theory of depression, Medical Hypotheses, 35, 298, 10.1016/0306-9877(91)90272-Z Smith, 1995, The macrophage-T-lymphocyte theory of schizophrenia: additional evidence, Medical Hypotheses, 45, 135, 10.1016/0306-9877(95)90062-4 Soderlund, 2011, Elevation of cerebrospinal fluid interleukin-1ss in bipolar disorder, Journal of Psychiatry and Neuroscience, 36, 114, 10.1503/jpn.100080 Soreca, 2008, Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder, Journal of Psychiatric Research, 42, 956, 10.1016/j.jpsychires.2007.10.009 Soreca, 2009, The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?, Depression and Anxiety, 26, 73, 10.1002/da.20521 Steckert, 2010, Role of oxidative stress in the pathophysiology of bipolar disorder, Neurochemical Research, 35, 1295, 10.1007/s11064-010-0195-2 Stertz, 2013, Is bipolar disorder an inflammatory condition? The relevance of microglial activation, Current Opinion in Psychiatry, 26, 19, 10.1097/YCO.0b013e32835aa4b4 Su, 2002, Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission, Journal of Affective Disorders, 71, 205, 10.1016/S0165-0327(01)00369-X Taylor, 2011, Alterations in cytokine and adipokine levels over two years of follow up in first episode patients with bipolar disorder, Bipolar Disorders, 13, 98 Taylor, 2009, Alterations in cytokines and adiponectine levels over two years of follow up in patients with mood disorders, Biological Psychiatry, 1, 67S Teixeira, 2011, Investigation of immunologic parameters and neurotrophic factors in bipolar disorder: trait or state?, Bipolar Disorders, 13, 99 Terres, 1998, The role of IL-4 and IL-10 cytokines in controlling an anti-tumor response in vivo, International Immunology, 10, 823, 10.1093/intimm/10.6.823 Tollerud, 1994, Racial variation in serum-soluble interleukin-2 receptor levels: a population-based study of healthy smokers and nonsmokers, Clinical Immunology and Immunopathology, 70, 274, 10.1006/clin.1994.1040 Torrey, 2012, Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas, Clinical Schizophrenia and Related Psychoses, 5, 208, 10.3371/CSRP.5.4.5 Tsai, 1999, Activation of indices of cell-mediated immunity in bipolar mania, Biological Psychiatry, 45, 989, 10.1016/S0006-3223(98)00159-0 Tsai, 2010, No state-dependent alternation of immunological parameters, insulin, and leptin during bipolar depression, European Neuropsychopharmacology, 20, S419, 10.1016/S0924-977X(10)70603-9 Tsai, 2012, Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder, Journal of Affective Disorders, 136, 110, 10.1016/j.jad.2011.08.022 Tsai, 2001, Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania, Journal of Affective Disorders, 64, 185, 10.1016/S0165-0327(00)00252-4 Vuksan-Cusa, 2010, C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia, Psychiatria Danubina, 22, 275 Wadee, 2002, Serological observations in patients suffering from acute manic episodes, Human Psychopharmacology, 17, 175, 10.1002/hup.390 Xuan, 2012, Neuroprotective effects of valproic acid following transient global ischemia in rats, Life Sciences, 90, 463, 10.1016/j.lfs.2012.01.001 Zell, 1997, TNF-alpha and IL-1 alpha inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: evidence for primary impairment of mitochondrial function, Molecular and Cellular Biochemistry, 177, 61, 10.1023/A:1006896832582 Zhang, 2012, Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats, Neuroscience, 221, 140, 10.1016/j.neuroscience.2012.07.013